In last trading session, Bluebird bio Inc (NASDAQ:BLUE) saw 8.63 million shares changing hands with its beta currently measuring 0.84. Company’s recent per share price level of $0.91 trading at $0.02 or 2.50% at ring of the bell on the day assigns it a market valuation of $175.26M. That closing price of BLUE’s stock is at a discount of -507.69% from its 52-week high price of $5.53 and is indicating a premium of 5.49% from its 52-week low price of $0.86. Taking a look at company’s average trading volume volume of 8.39 million if we extend that period to 3-months.
Bluebird bio Inc (NASDAQ:BLUE) trade information
Upright in the green during last session for gaining 2.50%, in the last five days BLUE remained trading in the red while hitting it’s week-highest on Monday, 04/29/24 when the stock touched $0.91 price level, adding 6.94% to its value on the day. Bluebird bio Inc’s shares saw a change of -34.11% in year-to-date performance and have moved -1.47% in past 5-day. Bluebird bio Inc (NASDAQ:BLUE) showed a performance of -24.85% in past 30-days.
Bluebird bio Inc (BLUE) estimates and forecasts
The company is estimating its revenue growth to decrease by -268.40% in the current quarter and calculating -309.50% decrease in the next quarter. This year revenue growth is estimated to rise 881.40% from the last financial year’s standing.
11 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $10.16 million for the same. And 9 analysts are in estimates of company making revenue of $19.55 million in the next quarter that will end on Mar 2024. Company posted $62k and $2.38 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 16,287.10% while estimating it to be 721.10% for the next quarter.
In 2024, company’s earnings growth rate is likely to be around 10.88% while estimates for its earnings growth in next 5 years are of 45.80%.
BLUE Dividends
Bluebird bio Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
